Oxford Nanopore makes stellar debut on UK stock marketShares in DNA sequencing specialist Oxford Nanopore rocketed after the company made its debut on the London Stock Share XOxford Nanopore makes stellar debut on UK stock markethttps://pharmaphorum.com/news/oxford-nanopore-makes-stellar-debut-on-uk-stock-market/
Sensyne, Oxford University deploy AI to find asthma targetsOxford University and UK clinical artificial intelligence (AI) company Sensyne Health will partner on a project to find Share XSensyne, Oxford University deploy AI to find asthma targetshttps://pharmaphorum.com/news/sensyne-oxford-university-deploy-ai-to-find-asthma-targets/
UK groups get £12m funding for COVID-19 monitoring softwareResearchers at the Wellcome Sanger Institute in the UK are working on software to monitor the genome of Share XUK groups get £12m funding for COVID-19 monitoring softwarehttps://pharmaphorum.com/news/uk-groups-get-12m-funding-for-covid-19-monitoring-software/
$110m financing sets up US, Asia expansion for Sophia GeneticsSwiss medical data specialist Sophia Genetics has raised $110 million in an oversubscribed funding round that will be Share X$110m financing sets up US, Asia expansion for Sophia Geneticshttps://pharmaphorum.com/news/110m-financing-sets-up-us-asia-expansion-for-sophia-genetics/
The future of genomic medicine: can it fulfil its promises?Last week geneticist Dr Charles Steward shared with us his experiences of searching for a genetic cause for Share XThe future of genomic medicine: can it fulfil its promises?https://pharmaphorum.com/views-analysis-patients/the-future-of-genomic-medicine-can-it-fulfil-its-promises/
Searching for answers in rare epilepsyGeneticist Dr Charles Steward has spent his career studying the human genome – but his work became much Share XSearching for answers in rare epilepsyhttps://pharmaphorum.com/views-analysis-patients/searching-for-answers-in-rare-epilepsy/
Sophia Genetics launches AI tool to find COVID-19 ‘unknowns’Swiss medical data specialist Sophia Genetics has launched a platform that will sift through data generated at more Share XSophia Genetics launches AI tool to find COVID-19 ‘unknowns’https://pharmaphorum.com/news/sophia-genetics-launches-ai-tool-to-find-covid-19-unknowns/
NICE green lights Roche’s Rozlytrek for NTRK tumoursThe UK’s National Institute for Health and Care Excellence (NICE) has cleared Roche’s Rozlytrek for NTRK fusion-positive solid Share XNICE green lights Roche’s Rozlytrek for NTRK tumourshttps://pharmaphorum.com/news/nice-green-lights-roches-rozlytrek-for-ntrk-tumours/
UK starts human gene sequencing project to aid COVID-19 fightIn a landmark study, thousands of NHS patients will have their DNA studied to see how a person’s Share XUK starts human gene sequencing project to aid COVID-19 fighthttps://pharmaphorum.com/news/uk-starts-human-gene-sequencing-project-to-aid-covid-19-fight/
